Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease.
Din
S
S
Cochrane
C J
CJ
Noble
C L
CL
Satsangi
J
J
Arnott
I D R
ID
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000069285:Infliximab; D001379:Azathioprine